Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nose and Nasal Cavity01:24

Nose and Nasal Cavity

The nose is composed of an observable exterior segment (external nose) and an internal segment within the skull known as the nasal cavity (internal nose). The external nose, visible on the face, consists of a framework of bone and hyaline cartilage enveloped in skin and muscle and lined with a mucous membrane. This structure is supported by the frontal bone, nasal bones, and maxillary bone and is supplemented by a cartilaginous framework comprising the septal nasal cartilage, lateral nasal...
Suctioning the Nasopharyngeal Airway01:29

Suctioning the Nasopharyngeal Airway

Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Pharynx01:20

Pharynx

The pharynx, a tubular structure framed by skeletal muscle and lined with mucous membrane, extends continuously from the nasal cavities. It is segmented into three major areas: the nasopharynx, oropharynx, and laryngopharynx.
Nasopharynx
The nasopharynx, bordered by the conchae of the nasal cavity, serves exclusively as an air conduit. In its superior region, the pharyngeal tonsils or adenoids are located. These tonsils are clusters of lymphoid reticular tissue akin to a lymph node. The precise...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation.

Clinical and translational radiation oncology·2024
Same author

[Interprofessional recommendations on behalf of Société française de radiothérapie oncologique for the prevention, protection and management of cyberattacks in radiation oncology].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
Same author

Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancer.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
Same author

[Understanding/acceptance of radiotherapy: An ethical dilemma resolved by an ethics of care].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
Same author

[Securing the information system of health care organisations].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2022
Same author

[Radiation induced brachial plexopathy: Diagnosis, risk factors, principles of care].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2022

Related Experiment Video

Updated: Jun 6, 2026

The Flexible Rhino-Laryngoscope for Awake Nasotracheal Intubation
03:58

The Flexible Rhino-Laryngoscope for Awake Nasotracheal Intubation

Published on: August 2, 2024

[Nasopharyngeal cancer].

B Fleury1, M C Biston, X Montbarbon

  • 1Département de radiothérapie, Centre de lutte contre le cancer Léon-Bérard, 28, rue Laennec, 69008 Lyon, France. bxfleury@yahoo.fr

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|December 7, 2010
PubMed
Summary

This study provides recommendations for delineating nasopharyngeal cancer target volumes and planning treatments using intensity-modulated radiation therapy (IMRT). It details expected efficacy and toxicity based on anatomy and published experiences.

More Related Videos

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

Related Experiment Videos

Last Updated: Jun 6, 2026

The Flexible Rhino-Laryngoscope for Awake Nasotracheal Intubation
03:58

The Flexible Rhino-Laryngoscope for Awake Nasotracheal Intubation

Published on: August 2, 2024

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Nasopharyngeal cancer (NPC) treatment relies heavily on accurate target volume delineation.
  • Intensity-modulated radiation therapy (IMRT) is a standard treatment modality for NPC.
  • Standardized recommendations are needed for optimal IMRT planning in NPC.

Purpose of the Study:

  • To propose evidence-based recommendations for nasopharyngeal cancer target volume delineation.
  • To provide guidance on treatment planning for NPC using IMRT.
  • To describe anticipated treatment efficacy and toxicity profiles.

Main Methods:

  • Review of anatomical considerations in NPC.
  • Analysis of the natural history of nasopharyngeal tumors.
  • Synthesis of published experiences from multiple institutions using IMRT for NPC.

Main Results:

  • Established guidelines for defining the clinical target volume (CTV) and planning target volume (PTV) in NPC.
  • Outlined optimal IMRT planning parameters for NPC.
  • Summarized expected outcomes regarding tumor control and treatment-related toxicities.

Conclusions:

  • Standardized target volume delineation and IMRT planning are crucial for optimizing nasopharyngeal cancer treatment.
  • Adherence to these recommendations can improve treatment efficacy and minimize toxicity.
  • Further research may refine these guidelines based on evolving clinical data.